abstract |
The present invention relates to a pharmaceutical vaccine composition comprising at least one vaccine antigen and a live immune cell. These immune cells contain a portion of at least one activated T cell and serve as an adjuvant. Methods for the prevention and treatment of diseases such as cancer, infectious diseases, and autoimmune diseases using such pharmaceutical compositions are also included. |